Abstract
e16046 Background: Sipuleucel-T was the first cellular immunotherapy shown to prolong the life of patients with advanced prostate cancer. It was of interest to determine who were those patients mos...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have